● Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Condition: Advanced Solid Tumor · Metastatic Solid Tumor · Prostate Cancer · Sponsor: MOMA Therapeutics

PhasePhase 1

Planned participants220

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and preliminary clinical activity of MOMA-313 administered orally as a single agent or combination therapy in patients with homologous recombinant deficient solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

MOMA Clinical Trials · (857) 285-3677 · clinicaltrials@momatx.com

Always discuss trial participation with your own doctor first.

Locations (18)

Investigative Site #108	Goodyear, Arizona, United States	Recruiting
Investigative Site #101	La Jolla, California, United States	Recruiting
Investigative Site #111	San Francisco, California, United States	Completed
Investigative Site #104	Lake Mary, Florida, United States	Recruiting
Investigative Site #110	St Louis, Missouri, United States	Recruiting
Investigative Site #103	New York, New York, United States	Recruiting
Investigative Site #106	New York, New York, United States	Recruiting
Investigative Site #109	Philadelphia, Pennsylvania, United States	Recruiting
Investigative Site #107	Myrtle Beach, South Carolina, United States	Completed
Investigative Site #102	Nashville, Tennessee, United States	Recruiting
Investigative Site #105	San Antonio, Texas, United States	Completed
Investigative Site #112	Fairfax, Virginia, United States	Completed

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06545942